IntroductionThere has been a steady rise in the number of patients requiring therapy with anticoagulants or antiplatelet agents for various acute and chronic conditions. In dermatologic surgery patients, perioperative management of these drugs continues to be a challenge . For Germany, it is estimated that 1,000,000 individuals were on long‐term antithrombotic treatment in 2010 . At the same time, rising life expectancy and greater UV exposure due to changes in recreational behavior have resulted in an increase in the incidence of many types of skin cancer and thus in the need for dermatosurgical procedures . Since 1970, for example, there has been a tenfold increase in the incidence of melanoma in Germany .In dermatology, as in other specialties, there are large differences with respect to perioperative management of antithrombotic agents . In 2012, we investigated this issue in a survey of office‐ and hospital‐based dermatologsts in Germany . Our results suggested that patterns of practice were highly heterogeneous, especially for moderate and major procedures. For instance, 36.3 % (61/168) of office‐based dermatologists surveyed reported not discontinuing low‐dose aspirin (≤ 100 mg) when performing large excisions, whereas 42.9 % reported doing so prior to surgery. Similarly, 63.1 % (41/65) of hospital‐based dermatologists discontinued phenprocoumon prior
Journal Der Deutschen Dermatologischen Gesellschaft – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera